Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email AHA/NASPE guidelines for driving restriction following initiation of therapy for ventricular tachyarrhythmia Type of treatment and arrhythmia Noncommercial driving Commercial driving ICD or drugs for secondary prevention Sustained ventricular tachycardia (VT) Six months Indefinite Ventricular fibrillation Six months Indefinite ICD for primary prevention No symptomatic arrhythmia At least one week post ICD implantation If appropriate ICD therapy received, especially with symptoms of cerebral hypoperfusion, should apply restrictions for treatment for secondary prevention Indefinite Candidates for primary prevention Nonsustained VT with impaired consciousness Three months Six months unless ICD placed (see above) Nonsustained VT without impaired consciousness No restrictions (unless ICD placed; see above) No restrictions (unless ICD placed; see above) Idiopathic VT without impaired consciousness* Three months Six months unless ICD placed (see above) ICD: implantable cardioverter-defibrillator. * Idiopathic VT refers to VT occurring in patients with normal coronary arteries and normal ventricular function. Adapted from: Epstein, AE, Miles, WM, Benditt, DG, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996; 94:1147 and Epstein, AE, Baessler, CA, Curtis, AB, et al. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and Heart Rhythm Society. Circulation 2007; 115:1170.